Dr. Joshua John Larocque, MD, PhD

Dr. Larocque practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.

Dr. Larocque's NPI, 1679935266, was assigned on March 23, 2016. Dr. Larocque graduated from University of Wisconsin School of Medicine in 2016. Dr. Larocque holds Wisconsin license 75689.

Dr. Larocque's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 349-5150.

Dr. Larocque's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. Dr. Larocque is also affiliated with Froedtert Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Larocque to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Larocque practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Larocque's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Larocque is licensed in Wisconsin.

CMS data shows 93 Medicare services from Dr. Larocque across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $11,597 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Larocque in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Larocque's median patient age at 54, with 53% women.

In 2024, Dr. Larocque wrote 60 Medicare Part D claims for 17 patients. 92% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $710 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Larocque for performance year 2024, reported as part of a group. Dr. Larocque accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Larocque, published from 2013 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Electroencephalography, Attention and Memory, Short-Term. Dr. Larocque has published most often in Epilepsy Behav. Dr. Larocque's most frequent co-authors are Erin Caitlin Conrad, MD, Brian Litt, MD and Colin Ellis, MD.

CMS Open Payments shows 1 general payment to Dr. Larocque from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Jazz Pharmaceuticals Inc. paid the most, $77.

Dr. Larocque graduated from University of Wisconsin School of Medicine in 2016.